Erythrocyte echinocytosis in liver disease. Role of abnormal plasma high density lipoproteins.
Echinocytes were frequently found in patients with liver disease when their blood was examined in wet films, but rarely detected in dried, stained smears. When normal erythrocytes (discocytes) were incubated with physiologic concentrations of the abnormal high density lipoproteins (HDL) from some jaundiced patients, echinocytosis developed within seconds. Other plasma fractions were not echinocytogenic. There was a close correlation between the number of echinocytes found in vivo and the ability of the corresponding HDL to induce discocyte-echinocyte transformation. On incubation with normal HDL, echinocytes generated in vitro rapidly reverted to a normal shape, and echinocytes from patients showed a similar trend. Echinocytosis occurred without change in membrane cholesterol content, as did its reversal, and was not caused by membrane uptake of lysolecithin or bile acids. Abnormal, echinocytogenic HDL showed saturable binding to approximately 5,000 sites per normal erythrocyte with an association constant of 10(8) M-1. Nonechinocytogenic patient HDL and normal HDL showed only nonsaturable binding. Several minor components of electrophoretically separated erythrocyte membrane proteins bound the abnormal HDL; pretreatment of the cells with trypsin or pronase reduced or eliminated binding. Echinocytosis by abnormal HDL required receptor occupancy, rather than transfer of constituents to or from the membrane, because cells reversibly prefixed in the discoid shape by wheat germ agglutinin, and then exposed to abnormal HDL, did not become echinocytes when the HDL and lectin were successively removed. Binding did not cause dephosphorylation of spectrin. We conclude that the echinocytes of liver disease are generated from discocytes by abnormal HDL, and we infer that the shape change is mediated by cell-surface receptors for abnormal HDL molecules.
D002277:Carcinoma / Q000097:blood; D004910:Erythrocyte Membrane / Q000648:ultrastructure; D004913:Erythrocytes, Abnormal / Q000473:pathology* / Q000648:ultrastructure; D005260:Female; D006505:Hepatitis / Q000097:blood; D006519:Hepatitis, Alcoholic / Q000097:blood; D006521:Hepatitis, Chronic / Q000097:blood; D006689:Hodgkin Disease / Q000097:blood; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood*; D008103:Liver Cirrhosis / Q000097:blood; D008105:Liver Cirrhosis, Biliary / Q000097:blood; D008107:Liver Diseases / Q000097:blood*; D008297:Male; D010190:Pancreatic Neoplasms / Q000097:blood
D008075:Lipoproteins, HDL